ARC in Hemorrhagic Stroke

Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02386202

Enrollment

Registered

2015-03-11

Start date

2015-01-31

Completion date

2015-08-31

Last updated

2015-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Augmented Renal Clearance, Hemorrhagic Stroke

Brief summary

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.

Interventions

OTHERNo intervention

No interventions

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adults ≥ 18 years * Patients with hemorrhagic stroke * Anticipated length of stay in the neuroscience intensive care unit \> 48 hours * Informed consent provided by the patient or by the patient's designated medical proxy

Exclusion criteria

* Pregnancy * Patients with pre-existing renal dysfunction (chronic kidney disease stages 3 - 5) * Patients receiving renal replacement therapy * Patients with an admission serum creatinine \> 1.4 mg/dL * Patients with non-aneurysmal subarachnoid hemorrhage * Patients with history of nephrectomy or body mass index \< 18 kg/m2

Design outcomes

Primary

Measure	Time frame	Description
To describe the onset, magnitude, and change over time of ARC in patients with hemorrhagic stroke	Over neurosciences intensive care unit stay	Daily 8-hour urine collections will be performed to directly measure creatinine clearance up to ICU discharge

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026